Myoclonus;Myoklonien

Aktuelle Neurologie

Volumn 36, Issue 2, 2009, Pages 71-81

  Wolters, A ^a   Benecke, R ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Aetiology of myoclonus; Myoclonus; Myoclonus syndromes; Treatment of myoclonus

Indexed keywords

5 HYDROXYTRYPTOPHAN; CLONAZEPAM; ETIRACETAM; PIRACETAM; VALPROIC ACID;

BRAIN DISEASE; BRAIN INFECTION; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; DEGENERATIVE DISEASE; DISEASE CLASSIFICATION; HUMAN; METABOLIC DISORDER; MYOCLONUS; REVIEW; STORAGE DISEASE;

EID: 62549164293     PISSN: 03024350     EISSN: 14389428     Source Type: Journal    
DOI: 10.1055/s-0028-1090174     Document Type: Review

References (42)

1. Caviness JN, Brown P. Myoclonus: current concepts and recent advances. Lancet Neurol 2004; 3: 598-607
2. Caviness JN, AlvingJL, Maraganore DM et al. The incidence and prevalence of myoclonus in Olmsted County. Mayo Clin Proc 1999; 74: 565-569
3. Grinker RR, Serota H, Stein SI. Myoclonic epilepsy. Arch Neurol Psychiatry 1938; 40: 968-980
4. Brown P, Ridding MC, Werhahn KJ et al. Abnormalities of the balance between inhibition and excitation in the motor cortex of patients with cortical myoclonus. Brain 1996; 119: 309-317
5. Hanajima R, Ugawa Y, Okabe S et al. Interhemispheric interaction between the hand motor areas in patients with cortical myoclonus. Clin Neurophysiol 2001; 112: 793-799
6. Hanajima R, Okabe S, Terao Y et al. Difference in intracortical inhibition of the motor cortex between cortical myoclonus and focal hand dystonia. Clin Neurophysiol 2008; 119: 1400-1407
7. Li JY, Cunic DJ, Paradiso G et al. Electrophysiological features of myoclonus-dystonia. Mov Disord 2008; 23: 312-316
8. Shibasaki H, Hallett M. Electrophysiological studies of myoclonus. Muscle Nerve 2005; 31: 157-174
9. Roze E, Apartis E, Vidailhet M et al. Propriospinal myoclonus: utility of magnetic resonance diffusion tensor imaging and fiber tracking. Mov Disord 2007; 22: 1506-1509
10. Tai KK, Bhidayasiri R, Truong DD. Post-hypoxic animal model of myoclonus. Parkinsonism Relat Disord 2007; 13: 377-381
11. Tai KK, Truong DD. Brivaracetam is superior to levetiracetam in a rat model of post-hypoxic myoclonus. J Neural Transm 2007; 114: 1547-1551
12. Naumann M, Bayas A. Myokymie und Neuromyotonie. Das Neurophysiologie-Labor 2008; 30: 23-28
13. Tassinari CA, Rubboli G, Shibasaki H. Neurophysiology of positive and negative myoclonus. Electroencephalogr Clin Neurophysiol 1998; 107: 181-195
14. Obeso J, Artieda J, Burleigh A. Clinical aspects of negative myoclonus. Adv Neurol 1995; 67: 1-7
15. Rubboli G, Tassinari CA. Negative myoclonus. An overview of its clinical features, pathophysiological mechanisms, and management. Neurophysiol Clin 2006; 36: 337-343
16. Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol 2008; 4: 327-340
17. Verdugo RJ, Ochoa JL. Abnormal movements in complex regional pain syndrome: assessment of their nature. Muscle Nerve 2000; 23: 198-205
18. Munts A, Van Rootselaar AF, Van der Meer JN et al. Clinical and neuro-physiological characterization of myoclonus in complex regional pain syndrome. Mov Disord 2008; 23: 581-587
19. Kahrilas PJ, Shi G. Why do we hiccup? Gut 1997; 41: 712-713
20. Hallett M, Chadwick D, Adam Jet al. Reticular reflex myoclonus. J Neurol Neurosurg Psychiatry 1977; 40: 253-264
21. Asmus F, Hjermind LE, Dupont E et al. Genomic deletion size at the epsilon-sarcoglycan locus determines the clinical phenotype. Brain 2007; 130: 2736-2745
22. Magarinos-Ascone CM, Regidor I, Martinez-Castrillo JC et al. Pallidal stimulation relieves myoclonus-dystonia syndrome. J Neurol Neurosurg Psychiatry 2005; 76: 989-991
23. Kälviäinen R, Khyuppenen J, Koskenkorva P et al. Clinical picture of EP-MI-Unverricht-Lundborg disease. Epilepsia 2008; 49: 549-556
24. Shibasaki H, Yamashita Y, Neshige R et al. Pathogenesis of giant somatosensory evoked potentials in progressive myoclonic epilepsy. Brain 1985; 108: 225-240
25. Salazar G, Valls-Sole J, Marti MJ et al. Postural and action myoclonus in patients with parkinsonian type multiple system atrophy. Mov Disord 2000; 15: 77-83
26. Okuma Y, Fujishima K, Miwa H et al. Myoclonic tremulous movements in multiple system atrophy are a form of cortical myoclonus. Mov Disord 2005; 20: 451-456
27. Rodriguez ME, Artieda J, Zubieta JL et al. Reflex myoclonus in olivopontocerebellar atrophy. J Neurol Neurosurgery Psychiatry 1994; 57: 316-319
28. Strafella A, Ashby P, Lang E. Reflex myoclonus in cortical-basal ganglionic degeneration involves a transcortical pathway. Mov Disord 1997; 12: 360-369
29. Thompson PD, Day BL, Rothwell JC et al. The myoclonus in corticobasal degeneration: evidence for two forms of cortical reflex myoclonus. Brain 1994; 117: 1197-1207
30. Grosse P, Ktihn A, Cordivari C et al. Coherence analysis in the myoclonus of corticobasale degeneration. Mov Disord 2003; 18: 1345-1350
31. Caviness JN, Adler CH, Beach TG et al. Small amplitude cortical myoclonus in Parkinson's disease: physiology and clinical observations. Mov Disord 2002; 17: 657-662
32. Caviness JN, Adler CH, Beach TG et al. Myoclonus in Lewy body disorders. Adv Neurol 2002; 89: 23-30
33. Benecke R. Myoklonus, myoklonische Syndrome und ihre assoziierten Erkrankungen. In: Ceballos-Baumann A, Conrad B, Hrsg. Bewegungs-störungen, 2. Auflage. Stuttgart, New York: Thieme Verlag, 2005
34. Koth S, Tirschwell DL. Long-term neurological complications after hypoxic-ischemic encephalopathy. Semin Neurol 2006; 26: 422-431
35. Glass GA, Ahlskog JE, Matsumoto JY. Orthostatic myoclonus. A contributor to gait decline in selected elderly. Neurology 2007; 68: 1826-1830
36. Alvarez M, Caviness JN. Primary progressive myoclonus of aging. Mov Disord 2008; 23: 2062-2066
37. Chang VC, Frucht SJ. Myoclonus. Curr Treat Options Neurol 2008; 10: 222-229
38. Magaudda A, Gelisse P, Genton P. Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations. Epilepsia 2004; 45: 678-681
39. Alonso-Navarro H, Rubio L, Jimenez-Jimenez L. Refractory hiccup: successful treatment with gabapentin. Clin Neuropharmacol 2007; 30: 186-187
40. Gelisse P, Crespel A, Genton P. Dramatic effect of levetiracetam on negative epileptic myoclonus. Acta Neurol Scand 2003; 107: 202-203
41. Chi WM, Chua KS, Kong KH. Phenytoin-induced asterixis - uncommon or under-diagnosed. Brain Inj 2000; 14: 847-850
42. Fahn S. Definition and classification of myoclonus. Advances in Neurology. New York: Raven Press, 1986: 1-5